BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zezos P, Renner EL. Liver transplantation and non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(42): 15532-15538 [PMID: 25400437 DOI: 10.3748/wjg.v20.i42.15532]
URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15532.htm
Number Citing Articles
1
Naftali Presser, Jeffery L. Ponsky. Surgical Procedures on the Cirrhotic Patient2017; : 119 doi: 10.1007/978-3-319-52396-5_9
2
Peter J. Altshuler, Hien Dang, Adam M. Frank, Ashesh P. Shah, Jaime Glorioso, Tingting Zhan, Arturo Rios Diaz, Osama Shaheen, Carlo B. Ramirez, Warren R. Maley, Adam S. Bodzin. Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic SteatohepatitisLiver Transplantation 2022; 28(4): 623 doi: 10.1002/lt.26313
3
Suliman Al Humayed. Protective and therapeutic effects ofCrataegus aroniain non-alcoholic fatty liver diseaseArchives of Physiology and Biochemistry 2017; 123(1): 23 doi: 10.1080/13813455.2016.1205097
4
Incidence and Predictors of Liver-Related Events in Patients With Nonalcoholic Fatty Liver DiseaseJournal of Clinical and Experimental Hepatology 2023; 13(1): 37 doi: 10.1016/j.jceh.2022.09.007
5
Russell Rosenblatt, Amit Mehta, David Snell, Erika Hissong, Andrea Siobhan Kierans, Sonal Kumar. Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective AnalysisDigestive Diseases and Sciences 2019; 64(1): 262 doi: 10.1007/s10620-018-5295-x
6
Paulo Reis-Júnior, Ryan Tanigawa, Gustavo Heluani Antunes de Mesquita, Natalia Basan, Venâncio Alves, Luiz Augusto Carneiro D'Albuquerque, Wellington Andraus. Steatosis and steatohepatitis found in adults after death due to non-burn traumaClinics 2019; 74: e1070 doi: 10.6061/clinics/2019/e1070
7
Eugenia Tsai, Tai-Ping Lee. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient ElastographyClinics in Liver Disease 2018; 22(1): 73 doi: 10.1016/j.cld.2017.08.004
8
Roberto Pellicciari, Mark Pruzanski, Antimo Gioiello. Successful Drug Discovery2018; : 197 doi: 10.1002/9783527808694.ch8
9
Elisabete Martins, Ana Oliveira. NAFLD and cardiovascular diseasePorto Biomedical Journal 2018; 3(2): e2 doi: 10.1016/j.pbj.0000000000000002
10
Yuxiang Zhang, Romeo Papazyan, Manashree Damle, Bin Fang, Jennifer Jager, Dan Feng, Lindsey C. Peed, Dongyin Guan, Zheng Sun, Mitchell A. Lazar. The hepatic circadian clock fine-tunes the lipogenic response to feeding through RORα/γGenes & Development 2017; 31(12): 1202 doi: 10.1101/gad.302323.117
11
Madhangi Parameswaran, Hamzah A Hasan, Jafor Sadeque, Sharan Jhaveri, Chaithanya Avanthika, Abimbola E Arisoyin, Maulik B Dhanani, Swaroopa M Rath . Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)Cureus 2021;  doi: 10.7759/cureus.20776
12
Francesco De Chiara, Ainhoa Ferret-Miñana, Juan M. Fernández-Costa, Alice Senni, Rajiv Jalan, Javier Ramón-Azcón. Fatty Hepatocytes Induce Skeletal Muscle Atrophy In Vitro: A New 3D Platform to Study the Protective Effect of Albumin in Non-Alcoholic Fatty LiverBiomedicines 2022; 10(5): 958 doi: 10.3390/biomedicines10050958
13
Daniela Grimm, Markus Wehland, Thomas J. Corydon, Peter Richter, Binod Prasad, Johann Bauer, Marcel Egli, Sascha Kopp, Michael Lebert, Marcus Krüger. The effects of microgravity on differentiation and cell growth in stem cells and cancer stem cellsStem Cells Translational Medicine 2020; 9(8): 882 doi: 10.1002/sctm.20-0084
14
Yasuyo Urasaki, Chi Zhang, Ji-Xin Cheng, Thuc T. Le. Quantitative Assessment of Liver Steatosis and Affected Pathways with Molecular Imaging and Proteomic ProfilingScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-22082-6
15
M. Pilar Valdecantos, Virginia Pardo, Laura Ruiz, Luis Castro‐Sánchez, Borja Lanzón, Elisa Fernández‐Millán, Carmelo García‐Monzón, Ana I. Arroba, Águeda González‐Rodríguez, Fernando Escrivá, Carmen Álvarez, Francisco J. Rupérez, Coral Barbas, Anish Konkar, Jacqui Naylor, David Hornigold, Ana Dos Santos, Maria Bednarek, Joseph Grimsby, Cristina M. Rondinone, Ángela M. Valverde. A novel glucagon‐like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in miceHepatology 2017; 65(3): 950 doi: 10.1002/hep.28962
16
Atilla Engin. Obesity and LipotoxicityAdvances in Experimental Medicine and Biology 2017; 960: 443 doi: 10.1007/978-3-319-48382-5_19
17
Pegah Golabi, Haley Bush, Maria Stepanova, Cameron T. Locklear, Ira M. Jacobson, Alita Mishra, Gregory Trimble, Madeline Erario, Chapy Venkatesan, Issah Younossi, Zachary Goodman, Zobair M. Younossi. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) CirrhosisMedicine 2018; 97(31): e11518 doi: 10.1097/MD.0000000000011518
18
Zhengmao Song, Yun Wang, Pingli Lin, Kaichun Yang, Xilin Jiang, Junchen Dong, Shangjin Xie, Rong Rao, Lishan Cui, Feng Liu, Xuefeng Huang. Identification of key modules and driving genes in nonalcoholic fatty liver disease by weighted gene co-expression network analysisBMC Genomics 2023; 24(1) doi: 10.1186/s12864-023-09458-3
19
Neeraj K. Saxena, Frank A. Anania. Adipocytokines and hepatic fibrosisTrends in Endocrinology & Metabolism 2015; 26(3): 153 doi: 10.1016/j.tem.2015.01.002
20
Mei Hua Gao, Dimosthenis Giamouridis, N. Chin Lai, Evelyn Walenta, Vivian Almeida Paschoal, Young Chul Kim, Atsushi Miyanohara, Tracy Guo, Min Liao, Li Liu, Zhen Tan, Theodore P. Ciaraldi, Simon Schenk, Aditi Bhargava, Da Young Oh, H. Kirk Hammond. One-time injection of AAV8 encoding urocortin 2 provides long-term resolution of insulin resistanceJCI Insight 2016; 1(15) doi: 10.1172/jci.insight.88322
21
Nicholas R. L. Lind, Qingwen Qian, Ling Yang. ER Stress and Autophagy in Obesity and Nonalcoholic Fatty Liver DiseaseCurrent Pathobiology Reports 2017; 5(3): 289 doi: 10.1007/s40139-017-0145-7
22
Seo Young Kang, Ye-Jee Kim, Hye Soon Park. Trends in the Prevalence of Non-Alcoholic Fatty Liver Disease and Its Future Predictions in Korean Men, 1998–2035Journal of Clinical Medicine 2020; 9(8): 2626 doi: 10.3390/jcm9082626
23
Swapna Chaturvedi, Divya Tripathi, Naval Kishore Vikram, Kumble S. Madhusudan, Ravindra Pandey, Neena Bhatia. Association of Nutrient Intake with Non-Alcoholic Fatty Liver Disease and Liver Steatosis in Adult Indian Population –A Case Control StudySSRN Electronic Journal 2022;  doi: 10.2139/ssrn.4131079
24
Ivy K.M. Law, Michelle W. Cheng, David Q. Shih, Dermot P.B. McGovern, Hon Wai Koon. Antimicrobial Peptides in Gastrointestinal Diseases2018; : 35 doi: 10.1016/B978-0-12-814319-3.00003-9
25
Ulf Kulik, Frank Lehner, Jürgen Klempnauer, Jürgen Borlak. Primary non‐function is frequently associated with fatty liver allografts and high mortality after re‐transplantationLiver International 2017; 37(8): 1219 doi: 10.1111/liv.13404
26
Christopher D. Anderson. Liver Transplantation for NASH-Related CirrhosisCurrent Surgery Reports 2015; 3(8) doi: 10.1007/s40137-015-0101-6
27
Pengcheng Peter Zhang, Hailey H. Choi, Michael A. Ohliger. Detection of fatty liver using virtual non-contrast dual-energy CTAbdominal Radiology 2022; 47(6): 2046 doi: 10.1007/s00261-022-03482-9
28
Diptadip Dattaroy, Ratanesh Kumar Seth, Sutapa Sarkar, Diana Kimono, Muayad Albadrani, Varun Chandrashekaran, Firas Al Hasson, Udai P. Singh, Daping Fan, Mitzi Nagarkatti, Prakash Nagarkatti, Anna Mae Diehl, Saurabh Chatterjee. Sparstolonin B (SsnB) attenuates liver fibrosis via a parallel conjugate pathway involving P53-P21 axis, TGF-beta signaling and focal adhesion that is TLR4 dependentEuropean Journal of Pharmacology 2018; 841: 33 doi: 10.1016/j.ejphar.2018.08.040
29
Swapna Chaturvedi, Divya Tripathi, Naval Kishore Vikram, Kumble S. Madhusudan, Ravindra Mohan Pandey, Neena Bhatia. Association of nutrient intake with non-alcoholic fatty liver disease and liver steatosis in adult Indian population – A case control studyHuman Nutrition & Metabolism 2023; 32: 200188 doi: 10.1016/j.hnm.2023.200188
30
Hedyeh Ebrahimi, Mohammadreza Naderian, Amir Ali Sohrabpour. New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review ArticleMiddle East Journal of Digestive Diseases 2016; 8(3): 166 doi: 10.15171/mejdd.2016.29
31
Samir Softic, David E. Cohen, C. Ronald Kahn. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver DiseaseDigestive Diseases and Sciences 2016; 61(5): 1282 doi: 10.1007/s10620-016-4054-0
32
Shujie Lai, Yan Li, Yi Kuang, Hongli Cui, Yang Yang, Wenjing Sun, Kaijun Liu, Dongfeng Chen, Qixian Yan, Liangzhi Wen. PKCδ silencing alleviates saturated fatty acid induced ER stress by enhancing SERCA activityBioscience Reports 2017; 37(6) doi: 10.1042/BSR20170869
33
Liyun Yuan, Courtney L. Hanlon, Norah Terrault, Saleh Alqahtani, Hani Tamim, Michelle Lai, Behnam Saberi. Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United StatesAmerican Journal of Gastroenterology 2022; 117(3): 433 doi: 10.14309/ajg.0000000000001591
34
Nicholas N. Nissen, Alagappan Annamalai, Andrew Klein. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set2019; : 1488 doi: 10.1016/B978-0-323-40232-3.00127-8
35
Veeravich Jaruvongvanich, Anawin Sanguankeo, Sikarin Upala. Nonalcoholic Fatty Liver Disease Is Not Associated with Thyroid Hormone Levels and Hypothyroidism: A Systematic Review and Meta-AnalysisEuropean Thyroid Journal 2017; 6(4): 208 doi: 10.1159/000454920
36
Andrew S. Barbas, Nicolas Goldaracena, Martin J. Dib, David P. Al-Adra, Aloysious D. Aravinthan, Leslie B. Lilly, Eberhard L. Renner, Nazia Selzner, Mamatha Bhat, Mark S. Cattral, Anand Ghanekar, Ian D. McGilvray, Gonzalo Sapisochin, Markus Selzner, Paul D. Greig, David R. Grant. Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto ExperienceTransplantation Direct 2017; 3(6): e158 doi: 10.1097/TXD.0000000000000674
37
Jing Gao, Isain Zapata, Johnson Chen, Todd N. Erpelding, Colby Adamson, David Park. Quantitative Ultrasound Biomarkers to Assess Nonalcoholic Fatty Liver DiseaseJournal of Ultrasound in Medicine 2023; 42(8): 1675 doi: 10.1002/jum.16185
38
D Hoang-Yen Tran, D Hoang-Ngoc Tran, S A Mattai, T Sallam, C Ortiz, E C Lee, L Robbins, S Ho, J E Lee, E Fisseha, C Shieh, A Sideri, D Q Shih, P Fleshner, D P B McGovern, M Vu, T C Hing, K Bakirtzi, M Cheng, B Su, I Law, I Karagiannides, S R Targan, R L Gallo, Z Li, H W Koon. Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptorInternational Journal of Obesity 2016; 40(9): 1424 doi: 10.1038/ijo.2016.90
39
Abigail Wolf Greenstein, Neena Majumdar, Peng Yang, Papasani V Subbaiah, Rhonda D Kineman, Jose Cordoba-Chacon. Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult miceJournal of Endocrinology 2017; 232(1): 107 doi: 10.1530/JOE-16-0447
40
Jeremy Van, Costica Aloman, Nancy Reau. Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver DiseaseAmerican Journal of Gastroenterology 2021; 116(10): 2089 doi: 10.14309/ajg.0000000000001349
41
Naga Chalasani, Zobair Younossi, Joel E. Lavine, Michael Charlton, Kenneth Cusi, Mary Rinella, Stephen A. Harrison, Elizabeth M. Brunt, Arun J. Sanyal. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology 2018; 67(1): 328 doi: 10.1002/hep.29367
42
Childhood Obesity2016; : 293 doi: 10.1201/9781315370958-28
43
Fernando Ezquer, Javiera Bahamonde, Ya-Lin Huang, Marcelo Ezquer. Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomyStem Cell Research & Therapy 2017; 8(1) doi: 10.1186/s13287-016-0469-y
44
Mary Ellen Vajravelu, Emir Tas, Silva Arslanian. Pediatric Obesity: Complications and Current Day ManagementLife 2023; 13(7): 1591 doi: 10.3390/life13071591
45
Benedikt Kaufmann, Agustina Reca, Baocai Wang, Helmut Friess, Ariel E. Feldstein, Daniel Hartmann. Mechanisms of nonalcoholic fatty liver disease and implications for surgeryLangenbeck's Archives of Surgery 2021; 406(1): 1 doi: 10.1007/s00423-020-01965-1
46
E. Ramos-Tovar, P. Muriel. Liver Pathophysiology2017; : 743 doi: 10.1016/B978-0-12-804274-8.00053-9
47
Yuval A. Patel, Carl L. Berg, Cynthia A. Moylan. Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver TransplantationDigestive Diseases and Sciences 2016; 61(5): 1406 doi: 10.1007/s10620-016-4035-3
48
Hyoung-Yun Han, Sung-Kwon Lee, Bong-Keun Choi, Dong-Ryung Lee, Hae Jin Lee, Tae-Won Kim. Preventive Effect of <i>Citrus aurantium</i> Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in MiceBiological and Pharmaceutical Bulletin 2019; 42(2): 255 doi: 10.1248/bpb.b18-00702
49
Tomasz Charytoniuk, Krzysztof Drygalski, Karolina Konstantynowicz-Nowicka, Klaudia Berk, Adrian Chabowski. Alternative treatment methods attenuate the development of NAFLD: A review of resveratrol molecular mechanisms and clinical trialsNutrition 2017; 34: 108 doi: 10.1016/j.nut.2016.09.001
50
Izna Ali, Jason R. Slizgi, Josh D. Kaullen, Marija Ivanovic, Mikko Niemi, Paul W. Stewart, Alfred S. Barritt, Kim L.R. Brouwer. Transporter‐Mediated Alterations in Patients With NASH Increase Systemic and Hepatic Exposure to an OATP and MRP2 SubstrateClinical Pharmacology & Therapeutics 2018; 104(4): 749 doi: 10.1002/cpt.997
51
Myriam Alexander, A. Katrina Loomis, Jolyon Fairburn-Beech, Johan van der Lei, Talita Duarte-Salles, Daniel Prieto-Alhambra, David Ansell, Alessandro Pasqua, Francesco Lapi, Peter Rijnbeek, Mees Mosseveld, Paul Avillach, Peter Egger, Stuart Kendrick, Dawn M. Waterworth, Naveed Sattar, William Alazawi. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver diseaseBMC Medicine 2018; 16(1) doi: 10.1186/s12916-018-1103-x
52
Ana I. Álvarez-Mercado, Elsa Negrete-Sánchez, José Gulfo, Cindy G. Ávalos de León, Araní Casillas-Ramírez, María Eugenia Cornide-Petronio, Esther Bujaldon, Floriana Rotondo, Jordi Gracia-Sancho, Mónica B. Jiménez-Castro, Carmen Peralta. EGF-GH Axis in Rat Steatotic and Non-steatotic Liver Transplantation From Brain-dead DonorsTransplantation 2019; 103(7): 1349 doi: 10.1097/TP.0000000000002636
53
Bei Li, Chuan Zhang, Yu-Tao Zhan. Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and PrognosisCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/2784537
54
Shohei Narita, Satoshi Miuma, Sadayuki Okudaira, Yoshito Koga, Masanori Fukushima, Ryu Sasaki, Masafumi Haraguchi, Akihiko Soyama, Masaaki Hidaka, Hisamitsu Miyaaki, Mitsuru Futakuchi, Kazuhiro Nagai, Tatsuki Ichikawa, Susumu Eguchi, Kazuhiko Nakao. Regular protocol liver biopsy is useful to adjust immunosuppressant dose after adult liver transplantationClinical Transplantation 2023; 37(3) doi: 10.1111/ctr.14873
55
Mariabeatrice Principi, Andrea Iannone, Giuseppe Losurdo, Michela Mangia, Endrit Shahini, Francesca Albano, Salvatore Fabio Rizzi, Rosa Federica La Fortezza, Rosa Lovero, Antonella Contaldo, Michele Barone, Gioacchino Leandro, Enzo Ierardi, Alfredo Di Leo. Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk FactorsInflammatory Bowel Diseases 2018; 24(7): 1589 doi: 10.1093/ibd/izy051
56
C. Lynch, C. S. Chan, A. J. Drake. Early life programming and the risk of non-alcoholic fatty liver diseaseJournal of Developmental Origins of Health and Disease 2017; 8(3): 263 doi: 10.1017/S2040174416000805
57
Lindsay D. Plank, Kylie Russell. Nutrition in liver transplantationCurrent Opinion in Clinical Nutrition and Metabolic Care 2015; 18(5): 501 doi: 10.1097/MCO.0000000000000205
58
Daryl Ramai, Waqqas Tai, Michelle Rivera, Antonio Facciorusso, Nicola Tartaglia, Mario Pacilli, Antonio Ambrosi, Christian Cotsoglou, Rodolfo Sacco. Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular CarcinomaBiomedicines 2021; 9(2): 184 doi: 10.3390/biomedicines9020184
59
Ajay C Donepudi, Gregory J Smith, Oladimeji Aladelokun, Yoojin Lee, Steven J Toro, Marisa Pfohl, Angela L Slitt, Li Wang, Ji-Young Lee, John D Schuetz, José E Manautou. Lack of Multidrug Resistance-associated Protein 4 Prolongs Partial Hepatectomy-induced Hepatic SteatosisToxicological Sciences 2020; 175(2): 301 doi: 10.1093/toxsci/kfaa032
60
Kasper Ter Horst, Mireille Serlie. Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver DiseaseNutrients 2017; 9(9): 981 doi: 10.3390/nu9090981
61
Naomi Fleury, Sian Geldenhuys, Shelley Gorman. Sun Exposure and Its Effects on Human Health: Mechanisms through Which Sun Exposure Could Reduce the Risk of Developing Obesity and Cardiometabolic DysfunctionInternational Journal of Environmental Research and Public Health 2016; 13(10): 999 doi: 10.3390/ijerph13100999
62
Aaryani Tipirneni-Sajja, Sarah Brasher, Utsav Shrestha, Hayden Johnson, Cara Morin, Sanjaya K. Satapathy. Quantitative MRI of diffuse liver diseases: techniques and tissue-mimicking phantomsMagnetic Resonance Materials in Physics, Biology and Medicine 2022; 36(4): 529 doi: 10.1007/s10334-022-01053-z
63
Antonella Mosca, Silvio Veraldi, Andrea Dellostrologo, Mariateresa Sanseviero, Valerio Nobili. Pediatric Hepatology and Liver Transplantation2019; : 279 doi: 10.1007/978-3-319-96400-3_17
64
S. Hsieh, B. P. Leaderer, A. E. Feldstein, N. Santoro, L. A. McKay, S. Caprio, R. McConnell. Traffic‐related air pollution associations with cytokeratin‐18, a marker of hepatocellular apoptosis, in an overweight and obese paediatric populationPediatric Obesity 2018; 13(6): 342 doi: 10.1111/ijpo.12228
65
Michelle L. Aktary, Lindsay K. Eller, Alissa C. Nicolucci, Raylene A. Reimer. Cross-sectional analysis of the health profile and dietary intake of a sample of Canadian adults diagnosed with non-alcoholic fatty liver diseaseFood & Nutrition Research 2020; 64(0) doi: 10.29219/fnr.v64.4548
66
Yuhi Shimura, Kaori Kuramitsu, Masahiro Kido, Shohei Komatsu, Hidetoshi Gon, Kenji Fukushima, Takeshi Urade, Shinichi So, Toshihiko Yoshida, Keisuke Arai, Daisuke Tsugawa, Tadahiro Goto, Sadaki Asari, Hiroaki Yanagimoto, Hirochika Toyama, Tetsuo Ajiki, Takumi Fukumoto. Factors Predicting Over-Time Weight Increase After Liver Transplantation: A Retrospective StudyTransplantation Proceedings 2023; 55(4): 924 doi: 10.1016/j.transproceed.2023.03.045
67
Xiao-Long He, Li-Ting Wang, Xiang-Zhong Gu, Jie-Xin Xiao, Wen-Wei Qiu. A facile synthesis of ursodeoxycholic acid and obeticholic acid from cholic acidSteroids 2018; 140: 173 doi: 10.1016/j.steroids.2018.10.009
68
Utsav Shrestha, Marie van der Merwe, Nirman Kumar, Eddie Jacobs, Sanjaya K. Satapathy, Cara Morin, Aaryani Tipirneni‐Sajja. Morphological characterization of hepatic steatosis and Monte Carlo modeling of MRI signal for accurate quantification of fat fraction and relaxivityNMR in Biomedicine 2021; 34(6) doi: 10.1002/nbm.4489
69
Steve M. Nelson, Jason D. Hoskins, Christopher Lisanti, Jayanta Chaudhuri. Ultrasound Fatty Liver Indicator: A Simple Tool for Differentiating Steatosis From Nonalcoholic Steatohepatitis: Validity in the Average Obese PopulationJournal of Ultrasound in Medicine 2020; 39(4): 749 doi: 10.1002/jum.15154
70
Thomas Jensen, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan. Clinical workup of fatty liver for the primary care providerPostgraduate Medicine 2019; 131(1): 19 doi: 10.1080/00325481.2019.1546532
71
Meaghan Phipps, Alyson N. Fox, Robert S. Brown. Schiff's Diseases of the Liver2017; : 1053 doi: 10.1002/9781119251316.ch41
72
Annie J. Kruger, Bryan C. Fuchs, Ricard Masia, Jacinta A. Holmes, Shadi Salloum, Mozhdeh Sojoodi, Diego S. Ferreira, Stephanie M. Rutledge, Peter Caravan, Nadia Alatrakchi, Pam Vig, Eric Lefebvre, Raymond T. Chung. Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet‐induced mouse model of nonalcoholic steatohepatitisHepatology Communications 2018; 2(5): 529 doi: 10.1002/hep4.1160
73
Muhanad Elhafiz, Guolin Zhao, Mohammed Ismail, Dengqiu Xu, Debanjan Das, Sisi Fan, Nong Cheng, Bashir A. Yousef, Zhenzhou Jiang, Luyong Zhang. Imbalanced insulin substrate-1 and insulin substrate-2 signaling trigger hepatic steatosis in vitamin D deficient rats: 8-methoxypsoralen, a vitamin D receptor ligand with a promising anti-steatotic actionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(6): 158657 doi: 10.1016/j.bbalip.2020.158657
74
Love Sharma, Divya Gupta, Sheikh Tasduq Abdullah. Thioacetamide potentiates high cholesterol and high fat diet induced steato-hepatitic changes in livers of C57BL/6J mice: A novel eight weeks model of fibrosing NASHToxicology Letters 2019; 304: 21 doi: 10.1016/j.toxlet.2019.01.001
75
Andrea Bell, Soheila Korourian, Huawei Zeng, Joshua Phelps, Reza Hakkak. A diet containing a high- versus low-daidzein level does not protect against liver steatosis in the obese Zucker rat modelFood & Function 2017; 8(3): 1293 doi: 10.1039/C6FO01772J
76
Damiano Patrono, Silvia Martini, Renato Romagnoli. Non-Alcoholic Fatty Liver Disease2020; : 343 doi: 10.1007/978-3-319-95828-6_19
77
D. V. Sidorenko, V. D. Nazarov, S. V. Lapin, V. L. Emanuel. Role of molecular genetic factors in pathogenesis and diagnosis of non-alcoholic fatty liver disease (literature review and own data)Medical alphabet 2020; (5): 13 doi: 10.33667/2078-5631-2020-5-13-19
78
Chiara Saponaro, Melania Gaggini, Amalia Gastaldelli. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic MechanismsCurrent Diabetes Reports 2015; 15(6) doi: 10.1007/s11892-015-0607-4
79
Melissa Palmer, Lee Jennings, Debra G. Silberg, Caleb Bliss, Patrick Martin. A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitisBMC Pharmacology and Toxicology 2018; 19(1) doi: 10.1186/s40360-018-0200-y
80
Rhonda D. Kineman, Neena Majumdar, Papasani V. Subbaiah, Jose Cordoba-Chacon. Hepatic PPARγ Is Not Essential for the Rapid Development of Steatosis After Loss of Hepatic GH Signaling, in Adult Male MiceEndocrinology 2016; 157(5): 1728 doi: 10.1210/en.2015-2077
81
Frank T. Spradley, Jillian A. Smith, Barbara T. Alexander, Christopher D. Anderson. Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal diseaseAmerican Journal of Physiology-Endocrinology and Metabolism 2018; 315(5): E795 doi: 10.1152/ajpendo.00394.2017
82
Isabel Molwitz, Graeme Michael Campbell, Jin Yamamura, Tobias Knopp, Klaus Toedter, Roland Fischer, Zhiyue Jerry Wang, Alina Busch, Ann-Kathrin Ozga, Shuo Zhang, Thomas Lindner, Florian Sevecke, Mirco Grosser, Gerhard Adam, Patryk Szwargulski. Fat Quantification in Dual-Layer Detector Spectral Computed TomographyInvestigative Radiology 2022; 57(7): 463 doi: 10.1097/RLI.0000000000000858
83
Fumiaki Beppu, Haoqi Li, Kazuaki Yoshinaga, Toshiharu Nagai, Akihiko Yoshinda, Atsushi Kubo, Jota Kanda, Naohiro Gotoh. Dietary Starfish Oil Prevents Hepatic Steatosis and Hyperlipidemia in C57BL/6N Mice Fed High-fat DietJournal of Oleo Science 2017; 66(7): 761 doi: 10.5650/jos.ess17038
84
Andrew D. Posner, Samuel T. Sultan, Norann A. Zaghloul, William S. Twaddell, David A. Bruno, Steven I. Hanish, William R. Hutson, Laci Hebert, Rolf N. Barth, John C. LaMattina. Resolution of donor non‐alcoholic fatty liver disease following liver transplantationClinical Transplantation 2017; 31(9) doi: 10.1111/ctr.13032
85
Mary Chandrika Anton, B. Shanthi, Chaganti Sridevi. Prevalence of Non-Alcoholic Fatty Liver Disease in Urban Adult Population in a Tertiary Care Center, ChennaiIndian Journal of Community Medicine 2023; 48(4): 601 doi: 10.4103/ijcm.ijcm_437_22
86
Abhijit Chowdhury, Zobair M. Younossi. Alcoholic and Non-Alcoholic Fatty Liver Disease2016; : 21 doi: 10.1007/978-3-319-20538-0_2
87
Zobair M. Younossi. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantationLiver Transplantation 2018; 24(2): 166 doi: 10.1002/lt.25003
88
Yang Ji, Yingmin Liang, Judith C.W. Mak, Mary S.M. Ip. Obstructive sleep apnea, intermittent hypoxia and non-alcoholic fatty liver diseaseSleep Medicine 2022; 95: 16 doi: 10.1016/j.sleep.2022.04.006
89
Michael Karin. New insights into the pathogenesis and treatment of non-viral hepatocellular carcinoma: a balancing act between immunosuppression and immunosurveillancePrecision Clinical Medicine 2018; 1(1): 21 doi: 10.1093/pcmedi/pby005
90
Thomas G. Cotter, Michael Charlton. Nonalcoholic Steatohepatitis After Liver TransplantationLiver Transplantation 2020; 26(1): 141 doi: 10.1002/lt.25657
91
Mohammadreza Naderian, Heshmatollah Akbari, Morteza Saeedi, Amir Ali Sohrabpour. olyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled TrialMiddle East Journal of Digestive Diseases 2017; 9(1): 12 doi: 10.15171/mejdd.2016.46
92
Raphael Chevre, Laia Trigueros‐Motos, David Castaño, Tricia Chua, Maria Corlianò, Jay V. Patankar, Lareina Sng, Lauren Sim, Tan Liang Juin, Guillaume Carissimo, Lisa F. P. Ng, Cheryl Neo Jia Yi, Chelsea Chandani Eliathamby, Albert K. Groen, Michael R. Hayden, Roshni R. Singaraja. Therapeutic modulation of the bile acid pool byCyp8b1knockdown protects against nonalcoholic fatty liver disease in miceThe FASEB Journal 2018; 32(7): 3792 doi: 10.1096/fj.201701084RR
93
Marine Dubois, Maxime Ronot, Pauline Houssel-Debry, Vanessa Brun, Michel Rayar, Magali Auger, Luc Beuzit, Bruno Turlin, Christophe Aubé, Anita Paisant. Performance of B-mode ratio and 2D shear wave elastography for the detection and quantification of hepatic steatosis and fibrosis after liver transplantationEuropean Journal of Gastroenterology & Hepatology 2020; 32(2): 222 doi: 10.1097/MEG.0000000000001500
94
Seyed Reza Modares Mousavi, Bita Geramizadeh, Amir Anushiravani, Fardad Ejtehadi, Mohammad Hossein Anbardar, Maryam Moini. Correlation between Serum Ferritin Level and Histopathological Disease Severity in Non-alcoholic Fatty Liver DiseaseMiddle East Journal of Digestive Diseases 2018; 10(2): 90 doi: 10.15171/mejdd.2018.96
95
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver DisorderCurrent Drug Therapy 2024; 19(1): 20 doi: 10.2174/1574885518666230417111247
96
Anandhu Krishnan G, Rajsekar C S, Srikanth Moorthy, Rubalakshmi S, Saitheja Paidipelly, Sanju Sherji, Fifiya.K. Yusuf. HEPATIC STEATOSIS IN LIVER DONORS: A COMPARATIVE STUDY BETWEEN COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING – PROTON DENSITY FAT FRACTION BASED HEPATIC FAT GRADINGS.INDIAN JOURNAL OF APPLIED RESEARCH 2021; : 1 doi: 10.36106/ijar/1801854
97
Nina Gyorfi, Akos Odry, Zoltan Karadi, Peter Odry, Tibor Szakall, Bojan Kuljic, Attila Toth, Zoltan Vizvari. Development of Bioimpedance-based Measuring Systems for Diagnosis of Non-alcoholic Fatty Liver Disease2021 IEEE 15th International Symposium on Applied Computational Intelligence and Informatics (SACI) 2021; : 135 doi: 10.1109/SACI51354.2021.9465584
98
Marco Antonio Loera-Torres, Katya Cárdenas-Zurita, Eduardo Ríos-García, Eira Cerda-Reyes, José Antonio Morales-González. Papel de Nrf2 y estrés oxidativo en la progresión de esteatohepatitis no alcohólica a hepatocarcinomaCirujano General 2022; 44(1): 11 doi: 10.35366/109314
99
Penglei Ge, Huayu Yang, Jingfen Lu, Wenjun Liao, Shunda Du, Yingli Xu, Haifeng Xu, Haitao Zhao, Xin Lu, Xinting Sang, Shouxian Zhong, Jiefu Huang, Yilei Mao. Albumin Binding Function: The Potential Earliest Indicator for Liver Function DamageGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/5120760
100
Sharma Love, Malik A. Mudasir, Subhash C. Bhardwaj, Gurdarshan Singh, Sheikh A. Tasduq. Long-term administration of tacrolimus and everolimus prevents high cholesterol-high fructose-induced steatosis in C57BL/6J mice by inhibiting de-novo lipogenesisOncotarget 2017; 8(69): 113403 doi: 10.18632/oncotarget.15194
101
Max M. Puthenpura, Vishal Patel, John Fam, Leon Katz, David S. Tichansky, Stephan Myers. The Use of Transient Elastography Technology in the Bariatric Patient: a Review of the LiteratureObesity Surgery 2020; 30(12): 5108 doi: 10.1007/s11695-020-05002-4
102
John Vizuete, Alfredo Camero, Mazyar Malakouti, Karthik Garapati, Julio Gutierrez. Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future TherapiesJournal of Clinical and Translational Hepatology 2017; 5(1): 67 doi: 10.14218/JCTH.2016.00061
103
John Guirguis, Jagpreet Chhatwal, Jaividhya Dasarathy, John Rivas, David McMichael, Laura E. Nagy, Arthur J. McCullough, Srinivasan Dasarathy. Clinical Impact of Alcohol‐Related Cirrhosis in the Next Decade: Estimates Based on Current Epidemiological Trends in the United StatesAlcoholism: Clinical and Experimental Research 2015; 39(11): 2085 doi: 10.1111/acer.12887
104
Jiantao Ma, Shih-Jen Hwang, Alison Pedley, Joseph M. Massaro, Udo Hoffmann, Raymond T. Chung, Emelia J. Benjamin, Daniel Levy, Caroline S. Fox, Michelle T. Long. Bi-directional analysis between fatty liver and cardiovascular disease risk factorsJournal of Hepatology 2017; 66(2): 390 doi: 10.1016/j.jhep.2016.09.022
105
Abbas Ali Tasneem, Nasir Hassan Luck, Zain Majid. Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD)Tropical Doctor 2018; 48(2): 107 doi: 10.1177/0049475517742261
106
Sonali Paul, Michael Charlton. Surgical Issues in NASH: Bariatric Surgery and Liver TransplantationCurrent Hepatology Reports 2018; 17(4): 367 doi: 10.1007/s11901-018-0429-3
107
John T. Rose, Paola Vargas, Tara Seay, Arthur J. Pesch, Tessa Williams, Anita Sites, Zachary Henry, Patrick G. Northup, Shawn J. Pelletier, Jose Oberholzer, Curtis K. Argo, Nicolas Goldaracena. Lose Weight to Donate: Development of a Program to Optimize Potential Donors With Hepatic Steatosis or Obesity for Living Liver DonationTransplantation Direct 2021; 7(6): e702 doi: 10.1097/TXD.0000000000001161
108
Jonathan A. Dranoff. Coffee as chemoprotectant in fatty liver disease: caffeine-dependent and caffeine-independent effectsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2023; 324(6): G419 doi: 10.1152/ajpgi.00026.2023
109
Experimental and Clinical Transplantation 2016; 14(6) doi: 10.6002/ect.2015.0247
110
Alabagi Abdulla, Charity Reynolds, H Hesham A-Kader. Non-Alcoholic Fatty Liver Disease (NAFLD): The Search for a CureEuropean Medical Journal 2016; : 93 doi: 10.33590/emj/10314771
111
Shen-ping Tang, Xin-li Mao, Ya-hong Chen, Ling-ling Yan, Li-ping Ye, Shao-wei Li. Reactive Oxygen Species Induce Fatty Liver and Ischemia-Reperfusion Injury by Promoting Inflammation and Cell DeathFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.870239
112
Kazuyoshi Kon, Kenichi Ikejima, Maki Morinaga, Hiromi Kusama, Kumiko Arai, Tomonori Aoyama, Akira Uchiyama, Shunhei Yamashina, Sumio Watanabe. L‐carnitine prevents metabolic steatohepatitis in obese diabetic KK‐Ay miceHepatology Research 2017; 47(3) doi: 10.1111/hepr.12720
113
Warinda Susutlertpanya, Hirokazu Wakuda, Naoyuki Otani, Takuya Kuramoto, Li Li, Masae Kuranari, Ai Sekiguchi, Hideo Kudo, Tomohisa Uchida, Hiromitsu Imai, Naoto Uemura. Histological evaluation of nintedanib in non-alcoholic steatohepatitis miceLife Sciences 2019; 228: 251 doi: 10.1016/j.lfs.2019.05.014
114
Ivana Mikolasevic, Tajana Filipec-Kanizaj, Maja Mijic, Ivan Jakopcic, Sandra Milic, Irena Hrstic, Nikola Sobocan, Davor Stimac, Patrizia Burra. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?World Journal of Gastroenterology 2018; 24(14): 1491-1506 doi: 10.3748/wjg.v24.i14.1491
115
Zheng-Tao Liu, Tian-Chi Chen, Xiao-Xiao Lu, Jun Cheng, Hai-Yang Xie, Lin Zhou, Shu-Sen Zheng. PNPLA3 I148M variant affects non-alcoholic fatty liver disease in liver transplant recipientsWorld Journal of Gastroenterology 2015; 21(34): 10054-10056 doi: 10.3748/wjg.v21.i34.10054
116
G. Losurdo, A. Castellaneta, M. Rendina, S. Carparelli, G. Leandro, A. Di Leo. Systematic review with meta‐analysis: de novo non‐alcoholic fatty liver disease in liver‐transplanted patientsAlimentary Pharmacology & Therapeutics 2018; 47(6): 704 doi: 10.1111/apt.14521
117
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An updateMetabolism 2016; 65(8): 1109 doi: 10.1016/j.metabol.2016.05.003
118
Chan Wah Kheong, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. A Randomized Trial of Silymarin for the Treatment of Nonalcoholic SteatohepatitisClinical Gastroenterology and Hepatology 2017; 15(12): 1940 doi: 10.1016/j.cgh.2017.04.016
119
Rohan C. Siriwardana, Madunil Anuk Niriella, Anuradha Supun Dassanayake, Chandika Anuradha Habarakada Liyanage, Bhagya Gunetilleke, Hithanadura Janaka de Silva. Recurrence of graft steatosis after liver transplantation for cryptogenic cirrhosis in recently commenced liver transplant programIndian Journal of Gastroenterology 2016; 35(3): 222 doi: 10.1007/s12664-016-0653-0
120
Jie Yu, Xuesong Yang, Ya Luo, Xuefeng Yang, Mengxue Yang, Jin Yang, Jie Zhou, Feng Gao, Liting He, Jie Xu, Jonathan M. Peterson. Adverse effects of chronic exposure to nonylphenol on non-alcoholic fatty liver disease in male ratsPLOS ONE 2017; 12(7): e0180218 doi: 10.1371/journal.pone.0180218